Congratulations to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its Successful Listing

Congratulations to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its successful Listing on the Mainboard of HKSE on 8 October 2024

 

Zhejiang Taimei Medical Technology Co.,Ltd. (“Taimei”) is a digital solution provider focused on the pharmaceutical and medical device industry in China. The software is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. These cloud-based software covers critical use cases in the research and development and commercialization of innovative drugs and medical devices. In addition to software, Taimei also provide a range of digital services, primarily assisting customers with independent reading of medical images, achieving efficient site management organization resource distribution and execution, offering pharmacovigilance services and other services to support customers’ the research and development and commercialization activities.

 

With regard to this listing application, AVISTA Group is honoured to be engaged in providing valuation services in relation to employee stock plan, M&A and financing transactions.

 

Congratulations again to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its successful listing. The issue price is HKD 13.00 per share, and the amount of funds raised is HKD 259.5 million.